BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 26150144)

  • 1. A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease.
    Nickol AH; Frise MC; Cheng HY; McGahey A; McFadyen BM; Harris-Wright T; Bart NK; Curtis MK; Khandwala S; O'Neill DP; Pollard KA; Hardinge FM; Rahman NM; Armitage AE; Dorrington KL; Drakesmith H; Ratcliffe PJ; Robbins PA
    BMJ Open; 2015 Jul; 5(7):e007911. PubMed ID: 26150144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise hypoxaemia as a predictor of pulmonary hypertension in COPD patients without severe resting hypoxaemia.
    Nakahara Y; Taniguchi H; Kimura T; Kondoh Y; Arizono S; Nishimura K; Sakamoto K; Ito S; Ando M; Hasegawa Y
    Respirology; 2017 Jan; 22(1):120-125. PubMed ID: 27471142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of anaemia on lung function and exercise capacity in patients with stable severe chronic obstructive pulmonary disease.
    Guo J; Zheng C; Xiao Q; Gong S; Zhao Q; Wang L; He J; Yang W; Shi X; Sun X; Liu J
    BMJ Open; 2015 Oct; 5(10):e008295. PubMed ID: 26450428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron Depletion in Systemic and Muscle Compartments Defines a Specific Phenotype of Severe COPD in Female and Male Patients: Implications in Exercise Tolerance.
    Pérez-Peiró M; Alvarado M; Martín-Ontiyuelo C; Duran X; Rodríguez-Chiaradía DA; Barreiro E
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise-induced oxygen desaturation in COPD patients without resting hypoxemia.
    Andrianopoulos V; Franssen FM; Peeters JP; Ubachs TJ; Bukari H; Groenen M; Burtin C; Vogiatzis I; Wouters EF; Spruit MA
    Respir Physiol Neurobiol; 2014 Jan; 190():40-6. PubMed ID: 24121092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase-9 predicts pulmonary status declines in α1-antitrypsin deficiency.
    Omachi TA; Eisner MD; Rames A; Markovtsova L; Blanc PD
    Respir Res; 2011 Mar; 12(1):35. PubMed ID: 21429222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and clinical impact of iron deficiency and anaemia among outpatients with chronic heart failure: The PrEP Registry.
    von Haehling S; Gremmler U; Krumm M; Mibach F; Schön N; Taggeselle J; Dahm JB; Angermann CE
    Clin Res Cardiol; 2017 Jun; 106(6):436-443. PubMed ID: 28229219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron deficiency in non-anemic chronic obstructive pulmonary disease in a predominantly male population: an ignored entity.
    Rathi V; Ish P; Singh G; Tiwari M; Goel N; Gaur SN
    Monaldi Arch Chest Dis; 2020 Feb; 90(1):. PubMed ID: 32072798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is iron deficiency modulating physical activity in COPD?
    Martín-Ontiyuelo C; Rodó-Pin A; Sancho-Muñoz A; Martinez-Llorens JM; Admetlló M; Molina L; Gea J; Barreiro E; Chiaradía DAR
    Int J Chron Obstruct Pulmon Dis; 2019; 14():211-214. PubMed ID: 30666101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic inflammation up-regulates serum hepcidin in exacerbations and stabile chronic obstructive pulmonary disease.
    Tandara L; Grubisic TZ; Ivan G; Jurisic Z; Tandara M; Gugo K; Mladinov S; Salamunic I
    Clin Biochem; 2015 Dec; 48(18):1252-7. PubMed ID: 26164540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous iron and chronic obstructive pulmonary disease: a randomised controlled trial.
    Santer P; McGahey A; Frise MC; Petousi N; Talbot NP; Baskerville R; Bafadhel M; Nickol AH; Robbins PA
    BMJ Open Respir Res; 2020 Jun; 7(1):. PubMed ID: 32565444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anemia of chronic disease in chronic obstructive pulmonary disease: a case-control study of cardiopulmonary exercise responses.
    Boutou AK; Stanopoulos I; Pitsiou GG; Kontakiotis T; Kyriazis G; Sichletidis L; Argyropoulou P
    Respiration; 2011; 82(3):237-45. PubMed ID: 21576921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative outcome after coronary artery bypass grafting in chronic obstructive pulmonary disease.
    Manganas H; Lacasse Y; Bourgeois S; Perron J; Dagenais F; Maltais F
    Can Respir J; 2007; 14(1):19-24. PubMed ID: 17315054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 16. Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD.
    Oki Y; Kaneko M; Fujimoto Y; Sakai H; Misu S; Mitani Y; Yamaguchi T; Yasuda H; Ishikawa A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2869-2875. PubMed ID: 27920514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
    Zhang J; Lin XF; Bai CX
    Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intravenous ferric carboxymaltose on exercise capacity and quality of life in patients with COPD : A pilot study.
    Grasmuk-Siegl E; Urban MH; Scherrer S; Funk GC
    Wien Klin Wochenschr; 2023 Jan; 135(1-2):35-44. PubMed ID: 36044093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, determinants and clinical correlates of vitamin D deficiency in patients with Chronic Obstructive Pulmonary Disease in London, UK.
    Jolliffe DA; James WY; Hooper RL; Barnes NC; Greiller CL; Islam K; Bhowmik A; Timms PM; Rajakulasingam RK; Choudhury AB; Simcock DE; Hyppönen E; Walton RT; Corrigan CJ; Griffiths CJ; Martineau AR
    J Steroid Biochem Mol Biol; 2018 Jan; 175():138-145. PubMed ID: 28161533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic inflammation in chronic obstructive pulmonary disease: a population-based study.
    Garcia-Rio F; Miravitlles M; Soriano JB; Muñoz L; Duran-Tauleria E; Sánchez G; Sobradillo V; Ancochea J;
    Respir Res; 2010 May; 11(1):63. PubMed ID: 20500811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.